Skip to main content

Peer Review reports

From: Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses

Original Submission
27 Mar 2015 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
29 Sep 2015 Editorially accepted
16 Oct 2015 Article published 10.1186/s12883-015-0450-x

You can find further information about peer review here.

Back to article page